Newsbenzinga
What's Going On With Definium Therapeutics Stock Tuesday?
· Published
Article summary
Definium Therapeutics (DFTX) stock hits $38.24 after positive clinical data, but an 84.57 RSI signals the shares are currently overbought.
An excerpt from the original article.
Comments —
Loading comments…